Full Breakdown
US Health Secretary Robert F. Kennedy Jr. Pushes to Reduce Antidepressant Prescriptions
6/6/2026, 9:08:38 PM
HHS Deprescribing Initiative Targets Antidepressants
Last month, the Department of Health and Human Services (HHS) issued a directive urging physicians to cut antidepressant prescriptions for depression, especially in children, and to prioritize diet, social interaction, psychotherapy and exercise as first-line options. Kennedy framed the move as decisive action against a mental-health crisis.
Policy Roots and Kennedy’s Health Stance
Robert F. Kennedy Jr., appointed HHS secretary by former President Donald Trump, has repeatedly challenged mainstream medical consensus, from vaccine-autism claims to reshaping the food pyramid, and has dismissed the CDC vaccine advisory panel.
Antidepressant Use in the United States
BMJ analysis shows 33.9 % of Americans have taken an antidepressant, while a survey last year reported 17 % current use; the most common agents are SSRIs such as Lexapro, Prozac, Zoloft and Escitalopram.
Government and Professional Body Reactions
HHS counselled clinicians to “consider alternatives where possible” but stopped short of bans; the NHS affirmed that antidepressants treat depressive symptoms, and the Royal College of Psychiatrists cited evidence of benefit for moderate-to-severe depression. A Lancet editorial warned that politicisation at the NIH, FDA and CDC threatens US public-health capacity. A HHS spokesperson denied Reuters reports that the agency was considering bans on specific SSRIs.
Medical Community Pushback
Psychiatry scholars argue the plan oversimplifies depression; Joanna Moncrieff called it “not a medical problem” but a life-circumstance issue. Thorrun Govind noted non-pharmacological therapies are usually adjuncts, not replacements, and stressed that any approach must be evidence-based and integrated with medication. Sameer Jauhar stressed antidepressants halve relapse risk, while Niall J.A. Palmer warned the policy ignores psychiatric bed shortages and workforce gaps.
Unresolved Issues
The 33.9 % lifetime figure conflicts with the 17 % current-use survey; Reuters said HHS explored SSRI bans, a claim the agency denied. The Lancet editorial warned that politicisation of NIH, FDA and CDC could undermine the policy’s scientific basis. Data on low-income access to diet, exercise or therapy are absent.
Verbatim Quotes
- “clear and decisive action to confront our nation’s mental health crisis by addressing the overuse of psychiatric medications – especially among children” — Robert F. Kennedy Jr., HHS Secretary
- “It’s not a medical problem, it’s very likely due to your life circumstances,” — Joanna Moncrieff, Professor of Critical and Social Psychiatry, UCL
- “antidepressants will reduce your risk of relapse by a factor of two” — Sameer Jauhar, Clinical Associate Professor, Imperial College London
- “The way that Kennedy has drawn up this policy doesn’t account for other factors, such as limited beds for psychiatric care and shortages in the workforce.” — Niall J.A. Palmer, Senior Lecturer in US Politics, Brunel University
Future Outlook
Implementation timelines remain unclear, and the guidance has already drawn criticism from medical professionals. The world will see where US policy ends up regarding antidepressants. Kennedy’s supporters cite an 88 % approval rating among the MAGA base, while critics continue to challenge the policy.
